Quarter ended Quarter ended Year ended 30 Sept 30 September 2024 30 June 2025 Net asset value per share (‘NAV’) GBP 1 ...
HER2 positive breast cancer treatment market was valued at USD 8.56 billion in 2024 and is projected to reach USD 18.67 billion by 2033, growing at a CAGR of 9.1% over the forecast period. China state ...
Prima Additive has formally rebranded as AltForm, marking a strategic shift in focus from metal 3D printing toward a broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback